Dr. Ann Arvin, MD
Stanford, CA
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Arvin, Pediatric Infectious Diseases Specialist in Stanford, CA?
Dr. Ann Arvin, MD is a Pediatric Infectious Diseases Specialist, who primarily practices in Stanford, CA with 1 additional practice location. She is board certified. Dr. Arvin completed her residency at Mount Zion M C Univ Ca, Pediatrics; Moffitt Hosp Univ Of Ca, Pediatrics. Dr. Arvin is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Arvin’s office at (650) 497-8775.
What are Areas of Expertise for Dr. Arvin?
Dr. Ann Arvin, MD is a highly-rated, board-certified Pediatric Infectious Diseases Specialist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Arvin empowers patients to confidently navigate their health journey, specializing in Infectious Disease, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Arvin is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Arvin go to medical school and complete their residency?
Residency: Mount Zion M C Univ Ca, Pediatrics; Moffitt Hosp Univ Of Ca, Pediatrics | Moffitt Hospital University Of Ca
Medical School: University of Pa Sch of Med, Philadelphia Pa | Perelman School of Medicine University of Pennsylvania
Is Dr. Arvin board certified as a Pediatric Infectious Diseases Specialist?
Yes, Dr. Ann Arvin, MD is board certified by the American Board of Pediatrics
What languages does Dr. Arvin speak?
Dr. Arvin and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Pediatric Infectious Diseases Specialist like Dr. Arvin typically treat?
As a Pediatric Infectious Diseases Specialist, conditions treated by Dr. Ann Arvin may include:
Please contact Dr. Arvin's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Pediatric Infectious Diseases Specialist like Dr. Arvin typically perform?
As a Pediatric Infectious Diseases Specialist, procedures performed by Dr. Ann Arvin may include:
- Epidemiology Consultation
- Epidemiology Follow Up
- HIV / AIDS Consultation
- HIV / AIDS Follow Up
- Human Papillomavirus (HPV) Vaccine
- Infection Follow Up
- Lumbar Puncture
- Pertussis Vaccine
Please contact Dr. Arvin's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Arvin accept my insurance?
Please contact Dr. Arvin's office to confirm accepted insurance plans.
Where is Dr. Arvin's office located?
Recognitions
Publications
Herpes Simplex Virus 1 Tropism for Human Sensory Ganglion Neurons
, 2013
An immunoreceptor tyrosine-based inhibition motif in varicella
, 2013
3D Reconstruction of VZV Infected Cell Nuclei
, 2012
Sigl transducer and activator of transcription 3
, 2012
Structure-function alysis of varicella
, 2011
Disruption of PML Nuclear Bodies Is Mediated by ORF61 SUMO-Interacting Motifs
, 2011
Entrapment of Viral Capsids in Nuclear PML Cages Is an Intrinsic Antiviral Host Defense against
, 2011
Varicella-Zoster Virus Immediate-Early Protein 62 Blocks Interferon Regulatory Factor 3
, 2010
Functions of the unique N-termil region of glycoprotein E in the pathogenesis of varicella
, 2010
Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors.
, 2013
ORF11 Protein Interacts with the ORF9 Essential Tegument Protein in Varicella
, 2013
Identification of a Hydrophobic Domain in Varicella-Zoster Virus ORF61 Necessary for ORF61 Self
, 2013
Inte Immune Dysfunction is Associated with Enhanced Dise
, 2013
Investigation of varicella-zoster virus neurotropism
, 2011
Varicella-Zoster Virus Infection Triggers Formation of an Interleukin-1 beta
, 2011
Mutagenesis of Varicella-Zoster Virus Glycoprotein I
, 2011
Identification and functiol characterization of the Varicella zoster virus ORF11 gene product
, 2011
Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical
, 2011
Varicella-Zoster Virus Glycoprotein E Is a Critical Determint of Virulence in the SCID Mouse
, 2011
Impact of Varicella-Zoster Virus on Dendritic Cell Subsets in Human Skin during tural Infection
, 2010
Expression of Varicella-Zoster Virus Immediate
, 2010
Varicella-Zoster Virus Neurotropism in SCID Mouse-Human Dorsal Root Ganglia Xenografts
, 2010
Anti-Glycoprotein H Antibody Impairs the Pathogenicity of Varicella
, 2010
Varicella-Zoster Virus T Cell Tropism and the Pathogenesis of Skin Infection
, 2010
Alysis of the Functions of Glycoproteins E and I and Their Promoters During VZV Replication In
, 2010
Age-Related Increase in the Frequency of CD4
, 2009
Mutagenesis of Varicella-Zoster Virus Glycoprotein B
, 2009
Regulation of the ORF61 Promoter and ORF61 Functions in Varicella
, 2009
Varicella in the fetus and newborn
, 2009
The Replication Cycle of Varicella-Zoster Virus
, 2009
One Step Closer to a CMV Vaccine
, 2009
Deletion of the first cysteine-rich region of the varicella
, 2009
Development of recombint varicella
, 2008
Functions of Varicella-Zoster Virus ORF23 Capsid Protein in Viral Replication
, 2008
Influence of Prior Influenza Vaccition on Antibody and B-Cell Responses
, 2008
Baseline Levels of Influenza-Specific CD4 Memory T
, 2008
Immune responses to mumps vaccine in adults who were vaccited in childhood
, 2008
Effects of interleukin-12
, 2008
Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication
, 2008
Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia
, 2008
Primary vaccine failure after 1 dose of varicella vaccine in healthy children
, 2008
Phenotypic changes in influenza-specific CD8
, 2008
Varicella vaccine in the United States: A decade of prevention and the way forward
, 2008
Humoral and cellular immunity to varicella-zoster virus: An overview
, 2008
Deletion of the First Cysteine-Rich Region of the Varicella
, 2008
A self-excisable infectious bacterial artificial chromosome clone of varicella
, 2007
Age-dependent differences in IgG isotype
, 2007
Cellular and viral factors regulate
, 2007
Genetic alysis of varicella
, 2007
Aberrant infection and persistence of varicella
, 2007
The ubiquitous cellular transcriptiol factor USF targets the varicella
, 2007
Humoral and cellular immune responses in children given annual immunization with trivalent
, 2007
Effect of materl herpes simplex virus (HSV) serostatus and HSV type on risk of neotal herpes
, 2007
Comparison of the influenza virus-specific effector
, 2007
Cellular immune responses in children
, 2006
ORF66 protein kise function is required for T-cell tropism of varicella-zoster virus in vivo
, 2006
Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
, 2006
Essential functions of the unique N-termil region of the varicella
, 2006
Variability and gender differences in memory T cell immunity to varicella
, 2006
Materl herpes simplex virus antibody avidity and risk of neotal herpes
, 2006
Inhibition of the NF-kappa B pathway by varicella-zoster virus in vitro
, 2006
Control of varicella - Why is a two-dose schedule necessary?
, 2006
A phase 1 study of 4 live, recombint human cytomegalovirus Towne/Toledo chimeric vaccines
, 2006
Varicella-zoster virus open reading frame 10 is a virulence determint in skin cells but not in T
, 2006
Mutatiol alysis of the Varicella-Zoster virus ORF62/63 Intergenic region
, 2006
Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month
, 2006
New viral vaccines
, 2006
Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons
, 2006
Reducing the global burden of congenital rubella syndrome
, 2005
Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of
, 2005
Strengthening the tion's influenza vaccition system - A tiol vaccine advisory committee assessment
, 2005
T-Cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection
, 2005
Cell-type-dependent activation of the cellular EF-1 alpha promoter by the varicella-zoster virus
, 2005
Aging, immunity, and the varicella-zoster virus
, 2005
Varicella-zoster virus infection of human dorsal root ganglia in vivo
, 2005
Role of the varicella
, 2005
Varicella-Zoster virus pathogenesis and immunobiology
, 2005
Alysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka
, 2005
Chickenpox party or varicella vaccine?
, 2005
Differential requirement for cell fusion
, 2004
T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus
, 2004
Functions of the C-termil domain of varicella
, 2004
Varicella-zoster virus transfer to skin by T cells
, 2004
Varicella-zoster virus infection of human neural cells in vivo
, 2004
Vaccine development to prevent cytomegalovirus disease
, 2004
Humoral and cell-mediated immune responses to an early 2
, 2004
T cell immunity to measles viral proteins in infants and adults after measles immunization
, 2004
Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood
, 2004
Persistent and selective deficiency of CD4
, 2004
The immediate-early 63 protein of varicella-zoster virus
, 2004
Induction of cellular
, 2004
Strengthening the supply of routinely recommended vaccines in the United States
, 2003
Requirement of Varicella-zoster virus immediate-early 4 protein for viral replication
, 2003
Measles and mumps vaccition as a model to investigate the developing immune system
, 2003
Identification of CD8+ T cell epitopes in the immediate early 62 protein
, 2003
Construction of varicella-zoster virus recombints from parent Oka cosmids
, 2003
Differentiation of varicella
, 2003
Mutatiol alysis of open reading frames 62 and 71
, 2003
Long term antiviral suppression after treatment for neotal herpes infection
, 2003
Alysis of the frequencies and of the memory T cell phenotypes of human CD8
, 2003
Microarray alysis of host cell gene transcription in response to varicella
, 2003
Varicella-zoster virus infection facilitates VZV glycoprotein E trafficking to the membrane surface
, 2003
Promoter sequences of varicella
, 2003
The requirement of varicella zoster virus glycoprotein E
, 2002
Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation
, 2002
Latent cytomegalovirus down
, 2002
The molecular epidemiology of varicella-zoster virus: Evidence for geographic segregation
, 2002
Glycoprotein I of Varicella-zoster virus is required for viral replication in skin and T cells
, 2002
Use of an ictivated varicella vaccine in recipients of hematopoietic-cell transplants
, 2002
Debate: the argument against
, 2002
Varlirix (GlaxoSmithKline).
, 2002
Memory cytotoxic T cell responses to viral tegument
, 2002
Antiviral therapy for varicella and herpes zoster.
, 2002
Quanitation of CD4+responder T cell frequencies to measles in vaccited infants and adults
, 2001
Immune responses to measles and mumps vaccition of infants at 6, 9, and 12 months
, 2001
Mutatiol alysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69
, 2001
Varicella-zoster virus: molecular virology and virus-host interactions
, 2001
Safety and efficacy of high
, 2001
tural history of neotal herpes simplex virus infections in the acyclovir era
, 2001
Varicella vaccine: Genesis, efficacy, and attenuation
, 2001
Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi
, 2001
Varicella vaccine - The first six years.
, 2001
Immune evasion as a pathogenic mechanism of varicella zoster virus
, 2001
Immune evasion mechanisms of varicella-zoster virus
, 2001
Granulysin blocks replication of varicella-zoster virus an
What is Dr. Arvin's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Arvin's National Provider Identifier (NPI) number is 1982748463.
What common questions do patients ask about Dr. Arvin?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Arvin
What is Dr. Ann Arvin's specialty?
Dr. Arvin is a Pediatric Infectious Diseases Specialist near Stanford, CA.
What does a Pediatric Infectious Diseases Specialist do?
A pediatrician trained in the diagnosis, treatment, and prevention of infectious diseases in children. This specialist utilizes their expertise to improve outcomes for pediatric infections, particularly those with complicated courses, underlying conditions that increase the risk of unusual or severe infections, ambiguous diagnoses, rare diseases, and complex or investigational treatments.
Is this Dr. Ann Arvin affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Arvin is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Pediatric Infectious Diseases Specialist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Pediatric Infectious Diseases Specialist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Ann Arvin accepting new patients in Stanford, CA?
Yes, Dr. Ann Arvin is accepting new patients at this time.
Does Dr. Ann Arvin offer online booking?
Please contact Dr. Arvin's office at (650) 497-8775 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Ann Arvin?
Please contact Dr. Arvin's office at (650) 497-8775 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Ann Arvin have?
Dr. Ann Arvin is certified by the American Board of Pediatrics.
Other Pediatric Infectious Diseases Specialist Near Stanford, CA
Pediatric Infectious Diseases Specialist
Accepting patients
Pediatric Infectious Diseases Specialist
Accepting patients
Pediatric Infectious Diseases Specialist
Accepting patients